Artemis Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-573
Closed -$42.9K 45
2023
Q3
$42.9K Buy
573
+6
+1% +$461 0.01% 39
2023
Q2
$43.7K Buy
567
+5
+0.9% +$399 0.01% 37
2023
Q1
$46.6K Buy
562
+5
+0.9% +$414 0.01% 30
2022
Q4
$47.8K Buy
557
+5
+0.9% +$396 0.01% 41
2022
Q3
$34K Buy
552
+6
+1% +$378 0.01% 54
2022
Q2
$33.7K Buy
546
+7
+1% +$433 0.01% 68
2022
Q1
$32.1K Buy
539
+6
+1% +$384 0.01% 46
2021
Q4
$38.7K Buy
533
+5
+0.9% +$344 ﹤0.01% 58
2021
Q3
$36.9K Buy
528
+6
+1% +$422 0.01% 55
2021
Q2
$36K Buy
522
+5
+1% +$334 0.01% 50
2021
Q1
$33.4K Buy
517
+6
+1% +$387 0.01% 51
2020
Q4
$29.8K Buy
511
+6
+1% +$362 ﹤0.01% 48
2020
Q3
$31.9K Buy
505
+5
+1% +$347 0.01% 49
2020
Q2
$38.5K Hold
500
0.01% 33
2020
Q1
$37.4K Hold
500
0.02% 29
2019
Q4
$32.5K Hold
500
0.01% 67
2019
Q3
$31.7K Hold
500
0.01% 16
2019
Q2
$33.8K Hold
500
0.02% 18
2019
Q1
$32.5K Hold
500
0.02% 18
2018
Q4
$31.3K Hold
500
0.02% 29
2018
Q3
$38.6K Hold
500
0.02% 18
2018
Q2
$35.4K Hold
500
0.03% 19
2018
Q1
$37.7K Hold
500
0.03% 20
2017
Q4
$35.8K Hold
500
0.03% 18
2017
Q3
$40.5K Hold
500
0.04% 14
2017
Q2
$35.4K Hold
500
0.03% 13
2017
Q1
$34K Buy
+500
New +$35.2K 0.03% 14

Other funds holding GILD

Artemis Wealth Advisors's GILD Position: Q4 2023 in Review

Artemis Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 573 shares — an estimated $42.9K sold.

Artemis Wealth Advisors first reported a position in GILD in Q1 2017 and held it in 27 quarters. The position peaked at $47.8K in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Artemis Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Artemis Wealth Advisors sold 573 Gilead Sciences shares in Q4 2023, an estimated $42.9K.
  • Artemis Wealth Advisors first reported a position in Gilead Sciences in Q1 2017 and held it in 27 quarters.
  • Artemis Wealth Advisors's Gilead Sciences position peaked at $47.8K in Q4 2022.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Artemis Wealth Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.